Stata DX Company
Stata DX is a developer of a disease management eRapid technology designed to implement custom biomarker panels for at-home patient monitoring in clinical studies.
The company's technology is a low-cost, affinity-based electrochemical sensing platform that can simultaneously detect a wide range of biomarkers in complex biological fluids, specifically liquid MRI for the brain, with high sensitivity and selectivity using as little as a single drop of blood, allowing researchers to learn about the composition of a system in real-time.
Stata DX was established in Cambridge, Massachusetts.
Total Funding:
3600000
Founded Date:
2022-01-01
Industry:
Electrometry
Last Funding Date:
2026-02-27
Funding Status:
private
Headquarters:
Cambridge,Massachusetts,United States,North America
Super Industry:
Quantum Sensing
Funding Stage:
Early Stage Venture
Funding Total Value:
3600000
Last Funding Total Usd:
400000
Last Funding Total Currency:
USD
Last Funding Total Value:
400000